In June 2020, the US Food and Drug Administration (FDA) published a guidance document outlining the impact of the COVID-19 pandemic on meetings and user fee applications for medical devices. The agency updated the guidance in December to extend compliance deadlines for medical device companies with applications and submissions on hold.